What does this research mean for the field?

Liver resection (LR) can provide a meaningful survival benefit in carefully selected patients with biologically favorable, liver-dominant non-colorectal liver metastases (NONCOLMET). Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to evaluate the survival benefits of liver resection in patients with non-colorectal liver metastases.

March 16, 2026Open Access

Liver Resection for Non-Colorectal Liver Metastases: The Good, the Bad and the Ugly

Key Points

This research aims to evaluate the survival benefits of liver resection in patients with non-colorectal liver metastases.
Analysis of selected patients with liver-dominant non-colorectal liver metastases
Focus on multidisciplinary evaluations and tumor-specific criteria
Comparison of outcomes based on selection criteria
Liver resection shows meaningful survival benefits in selected patients
Importance of careful patient selection and evaluation highlighted
Call for prospective studies to refine criteria further

Abstract

LR may provide meaningful survival benefit in carefully selected patients with biologically favorable, liver-dominant NONCOLMET. Multidisciplinary evaluation and tumor-specific selection criteria remain essential. Prospective studies are needed to refine indications.

Liver Resection for Non-Colorectal Liver Metastases: The Good, the Bad and the Ugly

Key Points

Abstract

Cite This Study